product details
Semaglutide (Sermaglutide) – GLP-1 Receptor Agonist for Metabolic Research
Semaglutide is a synthetic 31‑amino acid peptide analogue of human glucagon‑like peptide‑1 (GLP‑1) engineered for extended half‑life. It functions as a selective GLP‑1 receptor agonist, stimulating glucose‑dependent insulin secretion, delaying gastric emptying, and reducing appetite through central mechanisms. This peptide has become a standard reference tool in preclinical research for type 2 diabetes, obesity, and associated cardiometabolic conditions.
Key Research Applications:
•Type 2 Diabetes & Glycemic Control – Investigates glucose‑dependent insulin release and HbA1c reduction.
•Obesity & Energy Homeostasis – Studies appetite suppression, caloric intake, and body weight regulation.
•Cardiometabolic Research – Explores effects on lipid profiles, blood pressure, and vascular inflammation.
•Neuroendocrine & Reward Pathways – Examines GLP‑1 signalling in the central nervous system.
Product Specifications:
| Parameter | Detail |
|---|---|
| CAS Number | 910463-68-2 |
| Molecular Formula | C₁₈₇H₂₉₁N₄₅O₅₉ |
| Molecular Weight | ~4113.58 g/mol (free base) |
| Purity | ≥99% (by HPLC) |
| Physical Form | Lyophilized white powder |
| Storage | −20°C, protect from light |
| Intended Use | For laboratory research use only (RUO). Not for human or veterinary use. |